Eckert & Ziegler Strahlen- und Medizintechnik AG
A global provider of isotope technology for medical, scientific, and industrial use.
EUZ | F
Overview
Corporate Details
- ISIN(s):
- DE0005659700
- LEI:
- 391200EUDABLUKXCKG48
- Country:
- Germany
- Address:
- Robert-Rössle-Str. 10, 13125 Berlin
- Website:
- https://www.ezag.com/startseite/
- Sector:
- Manufacturing
Description
Eckert & Ziegler Strahlen- und Medizintechnik AG is a global provider of isotope technology for medical, scientific, and industrial use. The company's core business focuses on cancer therapy, industrial radiometry, and nuclear-medical imaging. It specializes in developing and manufacturing radioactive components and related equipment. Key offerings for the medical sector include products and services for nuclear medicine and radiation therapy, such as radiopharmaceuticals, radiosynthesis and quality control (QC) solutions, and sealed radiation sources. The company also provides essential infrastructure like hot cells and radiation protection solutions, supporting the radiopharmaceutical industry from early development through to commercial production.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-08 10:18 | English | 5.4 KB | |||
| 2024-02-28 10:00 |
Eckert & Ziegler Extends Ga-68 Activities in Japan
|
English | 7.3 KB | ||
| 2024-01-31 14:00 |
Eckert & Ziegler to Supply Nucleus Radiopharma with Therapeutic Radioisotopes A…
|
English | 9.4 KB | ||
| 2024-01-23 08:00 |
Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement …
|
English | 9.0 KB | ||
| 2024-01-08 10:00 |
Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for L…
|
English | 9.3 KB | ||
| 2023-11-22 16:02 |
First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) …
|
English | 7.2 KB | ||
| 2023-11-22 15:26 | English | 14.2 KB | |||
| 2023-11-21 15:26 |
Eckert & Ziegler: Personnel Changes in the Management. Changes in the Executive…
|
English | 7.2 KB | ||
| 2023-11-20 00:00 |
Q3 statement / Q3 financial report 2023
|
English | 1.8 MB | ||
| 2023-11-14 12:04 |
Eckert & Ziegler Establishes German-Chinese Joint Venture with DC Pharma for th…
|
English | 6.3 KB | ||
| 2023-11-14 07:45 |
Eckert & Ziegler with Significant Sales Growth in the First Nine Months of 2023
|
English | 7.4 KB | ||
| 2023-11-07 10:22 | English | 14.2 KB | |||
| 2023-10-23 09:00 |
Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinica…
|
English | 14.7 KB | ||
| 2023-10-20 15:40 |
Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024…
|
English | 11.0 KB | ||
| 2023-10-20 15:18 |
Eckert & Ziegler Focuses on Core Competence and Prepares Split-Off of Clinical …
|
English | 8.4 KB |
Automate Your Workflow. Get a real-time feed of all Eckert & Ziegler Strahlen- und Medizintechnik AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Eckert & Ziegler Strahlen- und Medizintechnik AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Eckert & Ziegler Strahlen- und Medizintechnik AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-30 | Eckert, Dr. Andreas | Supervisory board | Sell | None | 1,526,400.00 EUR |
| 2023-08-30 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,526,400.00 EUR |
| 2023-08-11 | Perschmann, Frank | Supervisory board | Buy | None | 16,600.00 EUR |
| 2023-01-13 | NEON Equity AG | Close relation | Buy | None | 2,115.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 57,402.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 32,160.00 EUR |
| 2023-01-11 | Bouterfa, Dr. Hakim | Board | Buy | None | 124,800.00 EUR |
| 2022-12-21 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,432,800.00 EUR |
| 2022-12-06 | Maennig, Prof. Dr. Wolfgang | Supervisory board | Buy | None | 72,745.31 EUR |
| 2022-12-05 | Carpio GmbH | Close relation | Buy | None | 73,826.53 EUR |
Peer Companies
